216 related articles for article (PubMed ID: 16448322)
1. Role of angiotensin II receptor blockers in atherosclerotic plaque stability.
Cipollone F; Fazia ML; Mezzetti A
Expert Opin Pharmacother; 2006 Feb; 7(3):277-85. PubMed ID: 16448322
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
Cipollone F; Fazia M; Iezzi A; Pini B; Cuccurullo C; Zucchelli M; de Cesare D; Ucchino S; Spigonardo F; De Luca M; Muraro R; Bei R; Bucci M; Cuccurullo F; Mezzetti A
Circulation; 2004 Mar; 109(12):1482-8. PubMed ID: 15037537
[TBL] [Abstract][Full Text] [Related]
3. [New insights on the molecular mechanisms of type-1 angiotensin II receptor blockers and their contribution to atherosclerotic plaque stabilization].
Mezzetti A; Fazia M; Cipollone F
Recenti Prog Med; 2004 Dec; 95(12):586-90. PubMed ID: 15666492
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological modulation of plaque instability.
Mezzetti A
Lupus; 2005; 14(9):769-72. PubMed ID: 16218485
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological properties and clinical efficacy of the long-active angiotensin receptor blocker (ARB) irbesartan].
Ariyoshi Y; Mizumoto K
Nihon Yakurigaku Zasshi; 2009 May; 133(5):275-80. PubMed ID: 19443965
[No Abstract] [Full Text] [Related]
6. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
7. Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.
Nussberger J; Aubert JF; Bouzourene K; Pellegrin M; Hayoz D; Mazzolai L
Hypertension; 2008 May; 51(5):1306-11. PubMed ID: 18391092
[TBL] [Abstract][Full Text] [Related]
8. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis.
Candido R; Allen TJ; Lassila M; Cao Z; Thallas V; Cooper ME; Jandeleit-Dahm KA
Circulation; 2004 Mar; 109(12):1536-42. PubMed ID: 15023892
[TBL] [Abstract][Full Text] [Related]
9. Dose-Effect of Irbesartan on Cyclooxygenase-2 and Matrix Metalloproteinase-9 Expression in Rabbit Atherosclerosis.
Li L; Li J; Yi J; Liu H; Lei H
J Cardiovasc Pharmacol; 2018 Feb; 71(2):82-94. PubMed ID: 29420356
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.
Yao R; Cheng X; Chen Y; Xie JJ; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH
Int J Cardiol; 2010 Mar; 139(2):113-22. PubMed ID: 19028402
[TBL] [Abstract][Full Text] [Related]
11. Improvement of coronary microvascular function after Angiotensin receptor blocker treatment with irbesartan in patients with systemic hypertension.
Lethen H; Tries HP; Kersting S; Bramlage P; Lambertz H
J Clin Hypertens (Greenwich); 2011 Mar; 13(3):155-61. PubMed ID: 21366846
[TBL] [Abstract][Full Text] [Related]
12. An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy.
García-Donaire JA; Segura J; Ruilope LM
Expert Opin Pharmacother; 2005 Aug; 6(9):1587-96. PubMed ID: 16086646
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation.
Clancy P; Koblar SA; Golledge J
Atherosclerosis; 2014 Sep; 236(1):108-15. PubMed ID: 25016365
[TBL] [Abstract][Full Text] [Related]
14. Role of the angiotensin converting enzyme 1/angiotensin II/angiotensin receptor 1 axis in interstitial collagenase expression in human carotid atheroma.
Clancy P; Seto SW; Koblar SA; Golledge J
Atherosclerosis; 2013 Aug; 229(2):331-7. PubMed ID: 23880184
[TBL] [Abstract][Full Text] [Related]
15. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
[TBL] [Abstract][Full Text] [Related]
16. Blockade of angiotensin II type 1 receptors: effect on carotid and radial artery structure and function in hypertensive humans.
Benetos A; Gautier S; Laflèche A; Topouchian J; Frangin G; Girerd X; Sissmann J; Safar ME
J Vasc Res; 2000; 37(1):8-15; discussion 68-70. PubMed ID: 10720881
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of irbesartan on plasma aldosterone concentration and left atrial volume in hypertensive patients.
Masaki M; Komamura K; Goda A; Hirotani S; Otsuka M; Nakabo A; Fukui M; Fujiwara S; Sugahara M; Lee-Kawabata M; Tsujino T; Koshiba M; Masuyama T
J Cardiol; 2014 Mar; 63(3):205-10. PubMed ID: 24060523
[TBL] [Abstract][Full Text] [Related]
18. Antiatherosclerotic effects of the novel angiotensin receptor antagonist Fimasartan on plaque progression and stability in a rabbit model: a double-blind placebo-controlled trial.
Lee JY; Lee CW; Kim WJ; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Son WC; Jung S; Park SW; Park SJ
J Cardiovasc Pharmacol; 2013 Aug; 62(2):229-36. PubMed ID: 23615162
[TBL] [Abstract][Full Text] [Related]
19. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.
Mörtsell D; Malmqvist K; Held C; Kahan T
J Intern Med; 2007 May; 261(5):472-9. PubMed ID: 17444886
[TBL] [Abstract][Full Text] [Related]
20. Enhanced platelet release of superoxide anion in systemic hypertension: role of AT1 receptors.
Germanò G; Sanguigni V; Pignatelli P; Caccese D; Lenti L; Ragazzo M; Lauro R; Violi F
J Hypertens; 2004 Jun; 22(6):1151-6. PubMed ID: 15167450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
